BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19298847)

  • 21. Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.
    Cohen G; Ettinger K; Lecht S; Lelkes PI; Lazarovici P
    J Mol Neurosci; 2014 Nov; 54(3):574-85. PubMed ID: 25078264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.
    Mei L; Nave KA
    Neuron; 2014 Jul; 83(1):27-49. PubMed ID: 24991953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window.
    Nawa H; Sotoyama H; Iwakura Y; Takei N; Namba H
    Biomed Res Int; 2014; 2014():697935. PubMed ID: 24949465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits.
    Pei JC; Liu CM; Lai WS
    Front Behav Neurosci; 2014; 8():126. PubMed ID: 24782733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain.
    Galvez-Contreras AY; Quiñones-Hinojosa A; Gonzalez-Perez O
    Front Cell Neurosci; 2013 Dec; 7():258. PubMed ID: 24381541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.
    Han M; Huang XF; Chen DC; Xiu M; Kosten TR; Zhang XY
    PLoS One; 2013; 8(6):e66299. PubMed ID: 23840437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
    Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
    Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions.
    Mizuno M; Sotoyama H; Namba H; Shibuya M; Eda T; Wang R; Okubo T; Nagata K; Iwakura Y; Nawa H
    Transl Psychiatry; 2013 Apr; 3(4):e252. PubMed ID: 23632456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What does a mouse tell us about neuregulin 1-cannabis interactions?
    Karl T; Arnold JC
    Front Cell Neurosci; 2013; 7():18. PubMed ID: 23447438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.
    Iwakura Y; Nawa H
    Front Cell Neurosci; 2013; 7():4. PubMed ID: 23408472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
    Deng C; Pan B; Engel M; Huang XF
    Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional upregulation of Ca(2+)-activated K(+) channels in the development of substantia nigra dopamine neurons.
    Ramírez-Latorre JA
    PLoS One; 2012; 7(12):e51610. PubMed ID: 23284723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain.
    Oyagi A; Hara H
    CNS Neurosci Ther; 2012 Oct; 18(10):803-10. PubMed ID: 23006514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF.
    Sotoyama H; Zheng Y; Iwakura Y; Mizuno M; Aizawa M; Shcherbakova K; Wang R; Namba H; Nawa H
    PLoS One; 2011; 6(10):e25831. PubMed ID: 22022452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuregulin-1 signals from the periphery regulate AMPA receptor sensitivity and expression in GABAergic interneurons in developing neocortex.
    Abe Y; Namba H; Kato T; Iwakura Y; Nawa H
    J Neurosci; 2011 Apr; 31(15):5699-709. PubMed ID: 21490211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation.
    Yoon S; Choi MH; Chang MS; Baik JH
    J Biol Chem; 2011 May; 286(18):15641-51. PubMed ID: 21454669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.
    Ting AK; Chen Y; Wen L; Yin DM; Shen C; Tao Y; Liu X; Xiong WC; Mei L
    J Neurosci; 2011 Jan; 31(1):15-25. PubMed ID: 21209185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic characterization of transgenic mice overexpressing neuregulin-1.
    Kato T; Kasai A; Mizuno M; Fengyi L; Shintani N; Maeda S; Yokoyama M; Ozaki M; Nawa H
    PLoS One; 2010 Dec; 5(12):e14185. PubMed ID: 21151609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.
    Balu DT; Coyle JT
    Neurosci Biobehav Rev; 2011 Jan; 35(3):848-70. PubMed ID: 20951727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression.
    Gómez-Casati ME; Murtie JC; Rio C; Stankovic K; Liberman MC; Corfas G
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):17005-10. PubMed ID: 20837532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.